I remember a few yrs back the drug Eldepryl (Selegline) was taken off the market for a while due to some deaths. Yet only a short time before that it was touted as possibly neuroprotective, it came back into favour and still is prescribed as far as I know
Then there's Tasmar, it's been known to cause liver failure and death so (it may have changed) but monthly liver function tests were/are mandatory.
These drugs are still given to parkinsonians.
I guess my point is who do we listen to and how much do we as patients want to risk the catastrophic events that can happen when we take a tablet, or undergo experimental procedures?
It's a really personal decision we do or don't take and open to debate.
In a way I'd like the general media to keep out of it but I guess they do there bit as a source of information to the public.
Lee